Predictors of Noncompliance to Antihypertensive Therapy among Hypertensive Patients Ghana: Application of Health Belief Model

International Journal of Hypertension
Yaa ObirikorangBeatrice Amoah

Abstract

This study determined noncompliance to antihypertensive therapy (AHT) and its associated factors in a Ghanaian population by using the health belief model (HBM). This descriptive cross-sectional study conducted at Kintampo Municipality in Ghana recruited a total of 678 hypertensive patients. The questionnaire constituted information regarding sociodemographics, a five-Likert type HBM questionnaire, and lifestyle-related factors. The rate of noncompliance to AHT in this study was 58.6%. The mean age (SD) of the participants was 43.5 (±5.2) years and median duration of hypertension was 2 years. Overall, the five HBM constructs explained 31.7% of the variance in noncompliance to AHT with a prediction accuracy of 77.5%, after adjusting for age, gender, and duration of condition. Higher levels of perceived benefits of using medicine [aOR=0.55(0.36-0.82),p=0.0001] and cue to actions [aOR=0.59(0.38-0.90),p=0.0008] were significantly associated with reduced noncompliance while perceived susceptibility [aOR=3.05(2.20-6.25), p<0.0001], perceived barrier [aOR=2.14(1.56-2.92), p<0.0001], and perceived severity [aOR=4.20(2.93-6.00),p<0.0001] were significantly associated with increased noncompliance to AHT. Participant who had completed ter...Continue Reading

References

Jan 1, 1984·Health Education Quarterly·N K Janz, M H Becker
Oct 1, 1995·American Journal of Hypertension·R W Sanson-Fisher, K Clover
Apr 24, 1999·Journal of Advanced Nursing·H Kyngäs, T Lahdenperä
Jan 5, 2002·European Journal of Clinical Pharmacology·J OkunoS Tomura
Dec 11, 2002·JAMA : the Journal of the American Medical Association·R Brian HaynesAmit X Garg
Mar 12, 2004·Transplantation Proceedings·A YavuzG Yakupoğlu
Sep 11, 2004·The European Respiratory Journal·M R WildC A Espie
Oct 16, 2004·Journal of Clinical Pharmacy and Therapeutics·N IiharaYuji Kurosaki
Mar 17, 2005·Cardiovascular Drugs and Therapy·Victoria SeniorUNKNOWN Genetic Risk Assessment for FH Trial (GRAFT) Study Group
Jun 9, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Eugenia Ch YiannakopoulouTheodoros D Mountokalakis
Apr 18, 2008·The European Respiratory Journal·S OlsenJ Douglas
Jan 8, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·J N Harvey, V L Lawson
Jul 16, 2010·BMC Public Health·William K Bosu
Mar 17, 2015·The Journal of Cardiovascular Nursing·Suzanne H S LoKai Chow Choi
Oct 29, 2015·International Journal of Hypertension·Vincent BoimaBamidele O Tayo
Feb 18, 2016·Cardiovascular Diagnosis and Therapy·Richard Ofori-Asenso, Daireen Garcia
Oct 19, 2016·Patient Education and Counseling·Shuaishuai YangYindong Li

❮ Previous
Next ❯

Citations

Feb 8, 2020·International Journal of Adolescent Medicine and Health·Mohammad Hosein FadaeiReza Goojani
Jun 11, 2019·BioMed Research International·Eddie-Williams OwireduBashiratu B Bazanfara
Jul 9, 2020·International Journal of Hypertension·Mohammed Gebre DedefoTesfa Tekle Dibessa
Jul 25, 2021·International Journal of Environmental Research and Public Health·Ni ZhouColman Patrick McGrath

❮ Previous
Next ❯

Software Mentioned

excel
statistical package for social sciences ( SPSS )

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.